| Identification | |
| Name: | Androst-4-ene-3,17-dione,4-hydroxy- |
| Synonyms: | 4-HAD;4-Hydroxyandrost-4-ene-3,17-dione;4-Hydroxyandrostene-3,17-dione;4-Hydroxyandrostenedione;4-OHA;CRC 82/01;Lentaron;NSC 282175; |
| CAS: | 566-48-3 |
| Molecular Formula: | C19H26O3 |
| Molecular Weight: | 302.4126 |
| InChI: | InChI=1/C19H26O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,22H,3-10H2,1-2H3/t11-,12-,13-,18+,19-/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.19g/cm3 |
| Refractive index: | 1.545 |
| Solubility: | Insoluble |
| Appearance: | White powder. |
| Usage: | An antitumor drug. An aromatase inhibitor |
| Safety Data | |
| Hazard Symbols |
T:Toxic
|
 |
|
